| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |